[1]
“Evaluation of multiple cellular, acellular, and matrix-like products (CAMPs) and standard of care versus standard of care alone in the treatment of nonhealing diabetic foot ulcers: an interim analysis of the CAMPFIRE clinical trial”, ijtr, vol. 1, no. Suppl 2, Oct. 2025, doi: 10.63676/t90w0b82.